Rhumbline Advisers Has $134.44 Million Position in Cencora, Inc. $COR

Rhumbline Advisers raised its stake in Cencora, Inc. (NYSE:COR) by 4.0% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 430,150 shares of the company’s stock after purchasing an additional 16,539 shares during the quarter. Rhumbline Advisers’ holdings in Cencora were worth $134,435,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. IFP Advisors Inc increased its stake in shares of Cencora by 30.4% in the second quarter. IFP Advisors Inc now owns 1,775 shares of the company’s stock worth $543,000 after acquiring an additional 414 shares during the last quarter. CWM LLC grew its stake in Cencora by 15.4% in the second quarter. CWM LLC now owns 11,792 shares of the company’s stock valued at $3,536,000 after purchasing an additional 1,575 shares in the last quarter. MGO One Seven LLC increased its position in Cencora by 30.6% in the 2nd quarter. MGO One Seven LLC now owns 3,298 shares of the company’s stock worth $989,000 after purchasing an additional 772 shares during the last quarter. Total Clarity Wealth Management Inc. purchased a new stake in shares of Cencora during the 2nd quarter worth about $221,000. Finally, Sequoia Financial Advisors LLC lifted its holdings in shares of Cencora by 3.1% during the 2nd quarter. Sequoia Financial Advisors LLC now owns 9,683 shares of the company’s stock valued at $2,903,000 after buying an additional 291 shares during the last quarter. Hedge funds and other institutional investors own 97.52% of the company’s stock.

Insider Activity at Cencora

In other Cencora news, EVP Silvana Battaglia sold 1,677 shares of Cencora stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $345.00, for a total value of $578,565.00. Following the transaction, the executive vice president directly owned 18,796 shares of the company’s stock, valued at $6,484,620. The trade was a 8.19% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Robert P. Mauch sold 5,096 shares of the company’s stock in a transaction that occurred on Tuesday, January 20th. The stock was sold at an average price of $354.73, for a total value of $1,807,704.08. Following the transaction, the chief executive officer owned 66,726 shares of the company’s stock, valued at approximately $23,669,713.98. This trade represents a 7.10% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 20,316 shares of company stock worth $7,151,265 in the last 90 days. 0.38% of the stock is owned by company insiders.

Cencora Price Performance

Shares of Cencora stock opened at $365.89 on Thursday. The company has a current ratio of 0.92, a quick ratio of 0.51 and a debt-to-equity ratio of 3.62. The firm has a fifty day simple moving average of $346.79 and a 200-day simple moving average of $327.66. The stock has a market capitalization of $70.98 billion, a price-to-earnings ratio of 43.98, a PEG ratio of 1.66 and a beta of 0.68. Cencora, Inc. has a 1-year low of $237.71 and a 1-year high of $377.54.

Cencora (NYSE:COR) last posted its earnings results on Wednesday, February 4th. The company reported $4.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.04 by $0.04. The business had revenue of $85.93 billion for the quarter, compared to analyst estimates of $86.12 billion. Cencora had a net margin of 0.50% and a return on equity of 176.54%. Cencora’s revenue was up 5.5% compared to the same quarter last year. During the same period last year, the business posted $3.73 EPS. On average, sell-side analysts expect that Cencora, Inc. will post 15.37 earnings per share for the current year.

Cencora Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 2nd. Stockholders of record on Friday, February 13th will be paid a $0.60 dividend. The ex-dividend date is Friday, February 13th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.7%. Cencora’s payout ratio is presently 28.85%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. Robert W. Baird set a $415.00 price objective on Cencora in a report on Tuesday, January 13th. Weiss Ratings raised shares of Cencora from a “hold (c+)” rating to a “buy (b)” rating in a research report on Thursday, February 5th. Wall Street Zen downgraded shares of Cencora from a “buy” rating to a “hold” rating in a report on Friday, November 28th. UBS Group lifted their price objective on shares of Cencora from $380.00 to $415.00 and gave the company a “buy” rating in a research note on Friday, November 7th. Finally, Evercore decreased their price objective on shares of Cencora from $440.00 to $420.00 and set an “outperform” rating for the company in a report on Thursday, February 5th. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $396.92.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.